Literature DB >> 21196917

Nicotine effects on rat seizures susceptibility and hippocampal neuronal degeneration.

Vladimír Riljak1, Dana Maresova, Jaroslav Pokorny.   

Abstract

OBJECTIVES: Nicotine is a widely used drug of abuse exerting number of effects on the central nervous system. The study was aimed at the effects of nicotine in various doses on the excitability of cerebral cortex and - by using the methods of histochemistry - to identify possible signs of neuronal degeneration after nicotine administration.
METHODS: Cortical afterdischarges were elicited by repeated stimulation of the right sensorimotor cortex. The duration of evoked ADs was monitored in animals treated with nicotine (0.75 or 1.0mg/kg) and in animals treated with saline. Methods of histochemistry (Fluoro-Jade B and bis-benzimide) were used to detect possible neuronal degeneration in hippocampus or in cerebral cortex.
RESULTS: No Fluoro-Jade B positive cells were found in hippocampi of control animals, or animals treated with nicotine. ADs length was significantly influenced by administration of nicotine.
CONCLUSION: Nicotine in 0.75 or 1.0 mg/kg dose leads to the decrease in ADs duration, influences the seizure susceptibility, and doesn't cause any detectable neuronal damage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196917

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  2 in total

1.  Early postnatal hypoxia induces behavioral deficits but not morphological damage in the hippocampus in adolescent rats.

Authors:  V Riljak; Z Laštůvka; J Mysliveček; V Borbélyová; J Otáhal
Journal:  Physiol Res       Date:  2019-12-19       Impact factor: 1.881

2.  Toxicity of nicotine by repeated intratracheal instillation to f344 rats.

Authors:  Masanao Yokohira; Yuko Nakano; Nozomi Hashimoto; Keiko Yamakawa; Fumiko Ninomiya; Sosuke Kishi; Kousuke Saoo; Katsumi Imaida
Journal:  J Toxicol Pathol       Date:  2012-12-20       Impact factor: 1.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.